Literature DB >> 30969905

Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program: Increasing Access to Screening.

Faye L Wong1, Jacqueline W Miller1.   

Abstract

The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured women across the nation. Although the program has provided services to more than 5 million women since 1991, there remains a significant burden of breast and cervical cancer with inequities among certain populations. To reduce this burden and improve health equity, the NBCCEDP is expanding its scope to include population-based strategies to increase screening in health systems and communities through the implementation of patient and provider evidence-based interventions, connecting women in communities to clinical services, increasing opportunities to access screening, and enhancing the targeting of women in need of services. The goal is to reach more women and make sure women are getting the right screening test at the right time.

Entities:  

Keywords:  breast cancer; cervical cancer; health equity; low income; screening

Mesh:

Year:  2019        PMID: 30969905      PMCID: PMC6727962          DOI: 10.1089/jwh.2019.7726

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  14 in total

1.  Health Reform, Medicaid Expansions, and Women's Cancer Screening.

Authors:  Leighton Ku; Tyler Bysshe; Erika Steinmetz; Brian K Bruen
Journal:  Womens Health Issues       Date:  2016-02-23

2.  Multilevel Small-Area Estimation of Colorectal Cancer Screening in the United States.

Authors:  Zahava Berkowitz; Xingyou Zhang; Thomas B Richards; Marion Nadel; Lucy A Peipins; James Holt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03       Impact factor: 4.254

3.  Breast cancer screening of underserved women in the USA: results from the National Breast and Cervical Cancer Early Detection Program, 1998-2012.

Authors:  David H Howard; Florence K L Tangka; Janet Royalty; Lucinda P Dalzell; Jacqueline Miller; Brett O'Hara; Kristy Joseph; Kristy Kenney; Gery Guy; Ingrid J Hall
Journal:  Cancer Causes Control       Date:  2015-03-17       Impact factor: 2.506

4.  Using data to effectively manage a national screening program.

Authors:  Brandie Yancy; Janet E Royalty; Steve Marroulis; Cindy Mattingly; Vicki B Benard; Amy DeGroff
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

5.  Multilevel Regression for Small-Area Estimation of Mammography Use in the United States, 2014.

Authors:  Zahava Berkowitz; Xingyou Zhang; Thomas B Richards; Susan A Sabatino; Lucy A Peipins; James Holt; Mary C White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-01       Impact factor: 4.254

6.  Public health national approach to reducing breast and cervical cancer disparities.

Authors:  Jacqueline W Miller; Marcus Plescia; Donatus U Ekwueme
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

7.  Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning.

Authors:  Nancy C Lee; Faye L Wong; Patricia M Jamison; Sandra F Jones; Louise Galaska; Kevin T Brady; Barbara Wethers; George-Ann Stokes-Townsend
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

8.  Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997-2012.

Authors:  Florence K L Tangka; David H Howard; Janet Royalty; Lucinda P Dalzell; Jacqueline Miller; Brett J O'Hara; Susan A Sabatino; Kristy Joseph; Kristy Kenney; Gery P Guy; Ingrid J Hall
Journal:  Cancer Causes Control       Date:  2015-03-18       Impact factor: 2.506

9.  Prevalence of Cancer Screening Among Adults With Disabilities, United States, 2013.

Authors:  C Brooke Steele; Julie S Townsend; Elizabeth A Courtney-Long; Monique Young
Journal:  Prev Chronic Dis       Date:  2017-01-26       Impact factor: 2.830

10.  Cancer Screening Test Use - United States, 2015.

Authors:  Arica White; Trevor D Thompson; Mary C White; Susan A Sabatino; Janet de Moor; Paul V Doria-Rose; Ann M Geiger; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-03-03       Impact factor: 17.586

View more
  5 in total

1.  Partnerships to expand worksite wellness programs - A qualitative analysis of state and local health department perspectives.

Authors:  Christine M Kava; Michelle Strait; Meagan C Brown; Kristen Hammerback; Jeffrey R Harris; Jeanne Alongi; Peggy A Hannon
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

2.  The association between social media use for health related information and compliance with breast and cervical cancer screenings.

Authors:  HyounKyoung G Park; Young-Il Kim; Warner K Huh; Sejong Bae
Journal:  Res Rep (Montgomery, Ala.)       Date:  2020-05-07

3.  Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.

Authors:  S Jane Henley; Cheryll C Thomas; Denise Riedel Lewis; Elizabeth M Ward; Farhad Islami; Manxia Wu; Hannah K Weir; Susan Scott; Recinda L Sherman; Jiemin Ma; Betsy A Kohler; Kathleen Cronin; Ahmedin Jemal; Vicki B Benard; Lisa C Richardson
Journal:  Cancer       Date:  2020-03-12       Impact factor: 6.921

4.  Role of Medicaid in Early Detection of Screening-Amenable Cancers.

Authors:  Cathy J Bradley; Lindsay M Sabik; Julia Entwistle; Jennifer L Stevens; Lindsey Enewold; Joan L Warren
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-06-01       Impact factor: 4.090

5.  COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.

Authors:  A DeGroff; J Miller; K Sharma; J Sun; W Helsel; W Kammerer; T Rockwell; A Sheu; S Melillo; J Uhd; K Kenney; F Wong; M Saraiya; L C Richardson
Journal:  Prev Med       Date:  2021-06-30       Impact factor: 4.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.